The Future of Pharma Evolutionary Threats and Opportunities

Compartir en:

Smith, Brian

(0 Comentarios)
Comenta y valora este libro

pvp.94,00 €

Disponible entre 11 y 20 dias

ISBN:9781409430315
Editorial: Gower Publishing
Fecha de la edición:2011
Encuadernación:
Dimensiones: 0 cm x 0 cm
Nº Pág.:212
Idiomas:Español

Materias:

/ Estructura Económica

By any standards, the pharmaceutical industry's history has been a successful one. In addition to its profits and
shareholder dividends, it has been seen by investors as relatively low risk and, largely, counter-cyclical to stock market
trends. However that important contribution appears to be petering out, with significant global implications for employees,
shareholders, governments and patients. This is not just caused by the economic crisis. Long before this, several distinct
but related streams of evidence emerged that now point to the stalling of the pharmaceutical industry.
The Future of Pharma examines the causes of the industry's potential decline and offers a convincing and rigorous
analysis of the options open to it. What emerges is a landscape defined, on the one hand, by the changing marketplace
of mass-market consumers, institutional healthcare systems and wealthy individuals; and on the other by the alternate
sources of commercial value - innovative therapies; super-efficient processes, supply chains and operations; and closer
customer relations and increasingly tailored health services.
The challenges to the pharmaceutical industry now and in the medium and long-term are very significant. Brian Smith's
highly readable research findings are a wake up call and a first-step forward for anyone concerned with the future of the
industry; whether executive, customer, policymaker or investor

Part I: Whither pharma? The world's most important industry at a fork in the road; Universal acid. A way to understand
the complex adaptive pharmaceutical industry. Part II: An evolving social environment; An evolving technological
environment; The evolution of the pharmaceutical industry; The speciation of pharma. The new business models that will
transform the industry. Part III: Sex, forced moves and good tricks. What new capabilities will be needed to survive and
thrive in the future of pharma?; Flat focused tribes. Organizational structures in the future of pharma; Gales of creative
destruction. The turmoil ahead of the pharmaceutical industry. Epilogue: unanswered questions and speculative
answers; Appendices; Index.